[HTML][HTML] Atheroprotective natural anti-phosphorylcholine antibodies of IgM subclass are decreased in Swedish controls as compared to non-westernized individuals …

J Frostegård, WJ Tao, A Georgiades, L Råstam… - Nutrition & …, 2007 - Springer
Objective To determine the importance of IgM antibodies against phosphorylcholine (aPC),
a novel protective factor for cardiovascular disease (CVD), in a population with a non …

[PDF][PDF] Atheroprotective natural anti-phosphorylcholine antibodies of IgM subclass are decreased in Swedish controls as compared to non-westernized individuals …

J Frostegård, WJ Tao, A Georgiades… - Nutrition & …, 2007 - scienceopen.com
Objective: To determine the importance of IgM antibodies against phosphorylcholine (aPC),
a novel protective factor for cardiovascular disease (CVD), in a population with a non …

Atheroprotective natural anti-phosphorylcholine antibodies of IgM subclass are decreased in Swedish controls as compared to non-westernized individuals from New …

J Frostegård, W Tao, A Georgiades… - Nutrition & …, 2007 - pubmed.ncbi.nlm.nih.gov
Objective To determine the importance of IgM antibodies against phosphorylcholine (aPC),
a novel protective factor for cardiovascular disease (CVD), in a population with a non …

Atheroprotective natural anti-phosphorylcholine antibodies of IgM subclass are decreased in Swedish controls as compared to non-westernized individuals from New …

J Frostegård, W Tao, A Georgiades, L Råstam… - Nutrition & …, 2007 - europepmc.org
Objective To determine the importance of IgM antibodies against phosphorylcholine (aPC),
a novel protective factor for cardiovascular disease (CVD), in a population with a non …

Atheroprotective natural anti-phosphorylcholine antibodies of IgM subclass are decreased in Swedish controls as compared to non-westernized individuals from New …

J Frostegard, WJ Tao, A Georgiades, L Råstam… - Nutrition & …, 2007 - lup.lub.lu.se
Objective: To determine the importance of IgM antibodies against phosphorylcholine (aPC),
a novel protective factor for cardiovascular disease (CVD), in a population with a non …

Atheroprotective natural anti-phosphorylcholine antibodies of IgM subclass are decreased in Swedish controls as compared to non-westernized individuals from New …

J Frostegard, WJ Tao, A Georgiades, L Rastam… - Nutrition & …, 2007 - go.gale.com
Objective To determine the importance of IgM antibodies against phosphorylcholine (aPC),
a novel protective factor for cardiovascular disease (CVD), in a population with a non …

[PDF][PDF] Atheroprotective natural anti-phosphorylcholine antibodies of IgM subclass are decreased in Swedish controls as compared to non-westernized individuals …

J Frostegård, WJ Tao, A Georgiades… - Nutrition & …, 2007 - researchgate.net
Objective: To determine the importance of IgM antibodies against phosphorylcholine (aPC),
a novel protective factor for cardiovascular disease (CVD), in a population with a non …

Atheroprotective natural anti-phosphorylcholine antibodies of IgM subclass are decreased in Swedish controls as compared to non-westernized individuals from New …

J Frostegård, TWJ Tao WenJing, A Georgiades… - 2007 - cabidigitallibrary.org
Objective: To determine the importance of IgM antibodies against phosphorylcholine (aPC),
a novel protective factor for cardiovascular disease (CVD), in a population with a non …

Atheroprotective natural anti-phosphorylcholine antibodies of IgM subclass are decreased in Swedish controls as compared to non-westernized individuals from New …

J Frostegard, W Tao, A Georgiades, L Rastam… - Nutrition and …, 2007 - hero.epa.gov
Objective: To determine the importance of IgM antibodies against phosphorylcholine (aPC),
a novel protective factor for cardiovascular disease (CVD), in a population with a non …

Atheroprotective natural anti-phosphorylcholine antibodies of IgM subclass are decreased in Swedish controls as compared to non-westernized individuals from New …

J Frostegard, WJ Tao, A Georgiades… - Nutrition & …, 2007 - portal.research.lu.se
Objective: To determine the importance of IgM antibodies against phosphorylcholine (aPC),
a novel protective factor for cardiovascular disease (CVD), in a population with a non …